Norris Medicines Limited (NORRIS.BO)
INR 17.61
(-1.62%)
INR 17.61
(-1.62%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.78 Million INR | -119.23% |
| 2022 | 9.27 Million INR | 1571.37% |
| 2021 | -630.44 Thousand INR | 96.38% |
| 2020 | -17.42 Million INR | 17.7% |
| 2019 | -21.16 Million INR | -254.32% |
| 2018 | -5.97 Million INR | 68.38% |
| 2017 | -18.89 Million INR | -2657.22% |
| 2016 | 738.74 Thousand INR | -92.65% |
| 2015 | 10.04 Million INR | -45.19% |
| 2014 | 18.33 Million INR | 275.96% |
| 2013 | -10.41 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.5 Million INR | -130.32% |
| 2023 Q1 | -3.71 Million INR | -169.7% |
| 2023 FY | - INR | -119.93% |
| 2023 Q4 | 4.89 Million INR | 1916.98% |
| 2023 Q3 | -269.44 Thousand INR | 89.05% |
| 2023 Q2 | -2.46 Million INR | 33.76% |
| 2022 Q3 | 3.48 Million INR | 39.82% |
| 2022 FY | - INR | 1571.37% |
| 2022 Q1 | -1.95 Million INR | 78.19% |
| 2022 Q2 | 2.49 Million INR | 227.75% |
| 2022 Q4 | 5.32 Million INR | 52.95% |
| 2021 FY | - INR | 96.38% |
| 2021 Q4 | -8.94 Million INR | -302.35% |
| 2021 Q3 | 4.41 Million INR | 444.06% |
| 2021 Q2 | -1.28 Million INR | -124.69% |
| 2021 Q1 | 5.2 Million INR | 151.15% |
| 2020 Q4 | -10.16 Million INR | -833.1% |
| 2020 FY | - INR | 17.7% |
| 2020 Q3 | 1.38 Million INR | 116.6% |
| 2020 Q2 | -8.35 Million INR | -5289.63% |
| 2020 Q1 | 161.05 Thousand INR | 101.81% |
| 2019 Q4 | -8.87 Million INR | -129.74% |
| 2019 FY | - INR | -254.32% |
| 2019 Q1 | -1.35 Million INR | -115.19% |
| 2019 Q2 | -7.2 Million INR | -433.63% |
| 2019 Q3 | -3.86 Million INR | 46.36% |
| 2018 Q1 | -6.22 Million INR | -91.86% |
| 2018 FY | - INR | 68.38% |
| 2018 Q4 | 8.88 Million INR | 245.93% |
| 2018 Q3 | -6.08 Million INR | -39.85% |
| 2018 Q2 | -4.35 Million INR | 30.11% |
| 2017 Q2 | -8.28 Million INR | -43.33% |
| 2017 FY | - INR | -2657.22% |
| 2017 Q1 | -5.78 Million INR | -3.29% |
| 2017 Q4 | -3.24 Million INR | -77.33% |
| 2017 Q3 | -1.83 Million INR | 77.91% |
| 2016 Q3 | 3.18 Million INR | 38.83% |
| 2016 Q2 | 2.29 Million INR | 478.83% |
| 2016 Q1 | 396 Thousand INR | -86.67% |
| 2016 FY | - INR | -92.65% |
| 2016 Q4 | -5.59 Million INR | -275.95% |
| 2015 FY | - INR | -45.19% |
| 2015 Q3 | 3.11 Million INR | -48.84% |
| 2015 Q2 | 6.08 Million INR | 165.73% |
| 2015 Q1 | 2.28 Million INR | -75.9% |
| 2015 Q4 | 2.97 Million INR | -4.56% |
| 2014 Q1 | 4.5 Million INR | 0.0% |
| 2014 FY | - INR | 275.96% |
| 2014 Q2 | 3.2 Million INR | -28.86% |
| 2014 Q3 | 3.86 Million INR | 20.58% |
| 2014 Q4 | 9.5 Million INR | 145.67% |
| 2013 FY | - INR | 0.0% |
| 2013 Q3 | 4.51 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | 101.968% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 102.16% |
| Bacil Pharma Limited | -569.32 Thousand INR | -213.382% |
| BDH Industries Limited | 124.27 Million INR | 101.436% |
| Beryl Drugs Limited | 26.63 Million INR | 106.697% |
| Cian Healthcare Limited | 122.56 Million INR | 101.456% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 110.801% |
| Concord Drugs Limited | 40.52 Million INR | 104.403% |
| Deccan Health Care Limited | 37.5 Million INR | 104.757% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 34.406% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 111.237% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 100.215% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | 379.316% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 100.472% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 115.008% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 100.292% |
| Panchsheel Organics Limited | 189.36 Million INR | 100.942% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 115.402% |
| Parnax Lab Limited | 243.59 Million INR | 100.732% |
| Makers Laboratories Limited | 25.81 Million INR | 106.912% |
| Medi-Caps Limited | 4.77 Million INR | 137.396% |
| MedPlus Health Services Limited | 3.94 Billion INR | 100.045% |
| Phaarmasia Limited | -1.58 Million INR | -12.778% |
| Parmax Pharma Limited | 22.93 Million INR | 107.778% |
| Patidar Buildcon Limited | -5.52 Million INR | 67.714% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 102.037% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -339.445% |
| Trident Lifeline Limited | 102.69 Million INR | 101.737% |
| Tyche Industries Limited | 128.2 Million INR | 101.392% |
| Vivanza Biosciences Limited | 11.2 Million INR | 115.924% |
| PRAVEG LIMITED | 321.43 Million INR | 100.555% |
| Smruthi Organics Limited | 120.31 Million INR | 101.483% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 103.982% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 100.702% |
| Sastasundar Ventures Limited | -203.51 Million INR | 99.123% |
| Transchem Limited | 56.61 Million INR | 103.152% |
| Trinity League India Limited | -26.25 Million INR | 93.204% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 100.461% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 94.49% |
| Sunil Healthcare Limited | 93.07 Million INR | 101.917% |
| Syschem (India) Limited | 70.4 Million INR | 102.534% |
| Zenith Healthcare Limited | 4.98 Million INR | 135.769% |
| Zenlabs Ethica Limited | 27.09 Million INR | 106.585% |
| Mercury Laboratories Limited | 101.18 Million INR | 101.763% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 102.004% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 102.118% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 98.819% |
| Roopa Industries Limited | 55.7 Million INR | 103.203% |
| PANJON LTD. | 4.08 Million INR | 143.633% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 98.553% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 90.635% |
| Anuh Pharma Limited | 878.5 Million INR | 100.203% |
| Crestchem Limited | 30.33 Million INR | 105.882% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 83.508% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 106.561% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 100.459% |
| Trimurthi Limited | -2.47 Million INR | 28.015% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 100.824% |
| Veerhealth Care Limited | 15.99 Million INR | 111.154% |
| Lactose (India) Limited | 201.22 Million INR | 100.887% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 98.145% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 101.046% |
| Gennex Laboratories Limited | 219.35 Million INR | 100.813% |
| Denis Chem Lab Limited | 224.84 Million INR | 100.793% |
| Colinz Laboratories Limited | 5.42 Million INR | 132.869% |
| Godavari Drugs Limited | 134.62 Million INR | 101.325% |
| Zenotech Laboratories Limited | 172.64 Million INR | 101.033% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 100.398% |
| Bharat Parenterals Limited | 265.74 Million INR | 100.671% |
| Coral Laboratories Limited | 227.07 Million INR | 100.786% |
| Evoq Remedies Limited | 6.18 Million INR | 128.832% |
| Kerala Ayurveda Limited | 70.78 Million INR | 102.52% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 79.189% |
| Natural Capsules Limited | 219.9 Million INR | 100.811% |
| Auro Laboratories Limited | 121.73 Million INR | 101.466% |